Similar articles for PMID: 17912251

Year	Number of Results
1998	1
1999	3
2000	1
2001	4
2002	4
2003	7
2004	8
2005	6
2006	5
2007	5
2008	9
2009	12
2010	4
2011	7
2012	4
2013	2
2014	5
2015	4
2016	4
2017	2
2018	3
2019	2
2020	2
2021	2
2022	1
2023	1
2024	0

1

Cellular plasticity cascades in the pathophysiology and treatment of bipolar disorder.

Schloesser RJ, Huang J, Klein PS, Manji HK. Schloesser RJ, et al. Neuropsychopharmacology. 2008 Jan;33(1):110-33. doi: 10.1038/sj.npp.1301575. Epub 2007 Oct 3. Neuropsychopharmacology. 2008. PMID: 17912251 Review.

2

Translating neurotrophic and cellular plasticity: from pathophysiology to improved therapeutics for bipolar disorder.

Soeiro-de-Souza MG, Dias VV, Figueira ML, Forlenza OV, Gattaz WF, Zarate CA Jr, Machado-Vieira R. Soeiro-de-Souza MG, et al. Acta Psychiatr Scand. 2012 Nov;126(5):332-41. doi: 10.1111/j.1600-0447.2012.01889.x. Epub 2012 Jun 8. Acta Psychiatr Scand. 2012. PMID: 22676371 Free PMC article. Review.

3

Glycogen Synthase Kinase-3β as a Putative Therapeutic Target for Bipolar Disorder.

Dandekar MP, Valvassori SS, Dal-Pont GC, Quevedo J. Dandekar MP, et al. Curr Drug Metab. 2018;19(8):663-673. doi: 10.2174/1389200219666171227203737. Curr Drug Metab. 2018. PMID: 29283064 Review.

4

Mitochondrially mediated plasticity in the pathophysiology and treatment of bipolar disorder.

Quiroz JA, Gray NA, Kato T, Manji HK. Quiroz JA, et al. Neuropsychopharmacology. 2008 Oct;33(11):2551-65. doi: 10.1038/sj.npp.1301671. Epub 2008 Jan 30. Neuropsychopharmacology. 2008. PMID: 18235426 Review.

5

The neuroprotective and neuroplastic potential of glutamatergic therapeutic drugs in bipolar disorder.

Guglielmo R, Hasler G. Guglielmo R, et al. Neurosci Biobehav Rev. 2022 Nov;142:104906. doi: 10.1016/j.neubiorev.2022.104906. Epub 2022 Oct 4. Neurosci Biobehav Rev. 2022. PMID: 36206993 Review.

6

Cellular mechanisms underlying affective resiliency: the role of glucocorticoid receptor- and mitochondrially-mediated plasticity.

Hunsberger JG, Austin DR, Chen G, Manji HK. Hunsberger JG, et al. Brain Res. 2009 Oct 13;1293:76-84. doi: 10.1016/j.brainres.2009.06.103. Epub 2009 Jul 10. Brain Res. 2009. PMID: 19595676 Free PMC article. Review.

7

New understanding of mechanisms of action of bipolar medications.

Sanacora G. Sanacora G. J Clin Psychiatry. 2008;69 Suppl 5:22-7. J Clin Psychiatry. 2008. PMID: 19265637 Review.

8

Targeting mitochondrially mediated plasticity to develop improved therapeutics for bipolar disorder.

de Sousa RT, Machado-Vieira R, Zarate CA Jr, Manji HK. de Sousa RT, et al. Expert Opin Ther Targets. 2014 Oct;18(10):1131-47. doi: 10.1517/14728222.2014.940893. Epub 2014 Jul 24. Expert Opin Ther Targets. 2014. PMID: 25056514 Free PMC article. Review.

9

Cellular plasticity cascades: targets for the development of novel therapeutics for bipolar disorder.

Zarate CA Jr, Singh J, Manji HK. Zarate CA Jr, et al. Biol Psychiatry. 2006 Jun 1;59(11):1006-20. doi: 10.1016/j.biopsych.2005.10.021. Epub 2006 Feb 17. Biol Psychiatry. 2006. PMID: 16487491 Review.

10

Bipolar disorder: from genes to behavior pathways.

Martinowich K, Schloesser RJ, Manji HK. Martinowich K, et al. J Clin Invest. 2009 Apr;119(4):726-36. doi: 10.1172/JCI37703. J Clin Invest. 2009. PMID: 19339764 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

96 results

Results by year